Epiminder is a groundbreaking brand that aims to provide freedom for those suffering from epilepsy. Their mission is to improve treatment using previously unseen data, and they have developed the innovative Minder® system to achieve this goal. Led by Professor Mark Cook, a global expert in neurology, Epiminder has created cutting-edge epilepsy treatments for over 30 years.

The Minder® system is currently under evaluation and has the potential to reveal unseen epileptic episodes, providing crucial data to clinicians and physicians for better treatment. This technology aims to address the uncertainties of drug therapy and the lack of complete information provided by current technology. Epiminder believes that more predictability, real-time data, and collaboration between patients and healthcare professionals can lead to greater inclusiveness and empowerment for epilepsy sufferers.

By capturing continuous data and utilizing artificial intelligence in the future, Epiminder hopes to achieve breakthroughs in predicting seizures and reducing drug usage. With their dedication to improving treatment through innovation and unseen data, Epiminder offers new hope to those affected by epilepsy